MX9200665A - Derivados de ureas y tioureas disubstituidas, procedimiento para su preparacion y composiciones farmaceuticas que los contiene. - Google Patents

Derivados de ureas y tioureas disubstituidas, procedimiento para su preparacion y composiciones farmaceuticas que los contiene.

Info

Publication number
MX9200665A
MX9200665A MX9200665A MX9200665A MX9200665A MX 9200665 A MX9200665 A MX 9200665A MX 9200665 A MX9200665 A MX 9200665A MX 9200665 A MX9200665 A MX 9200665A MX 9200665 A MX9200665 A MX 9200665A
Authority
MX
Mexico
Prior art keywords
alkyl
substituted
halogen
independently chosen
substituents independently
Prior art date
Application number
MX9200665A
Other languages
English (en)
Inventor
Paolo Cozzi
Daniel Fancelli
Dino Severino
Augusto Chiari
Giancarlo Ghiselli
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919103446A external-priority patent/GB9103446D0/en
Priority claimed from GB919106961A external-priority patent/GB9106961D0/en
Priority claimed from GB919126322A external-priority patent/GB9126322D0/en
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of MX9200665A publication Critical patent/MX9200665A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/20Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C275/24Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/06Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Treating Waste Gases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Exhaust Gas Treatment By Means Of Catalyst (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
MX9200665A 1991-02-19 1992-02-18 Derivados de ureas y tioureas disubstituidas, procedimiento para su preparacion y composiciones farmaceuticas que los contiene. MX9200665A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919103446A GB9103446D0 (en) 1991-02-19 1991-02-19 Disubstituted ureas and thioureas derivatives
GB919106961A GB9106961D0 (en) 1991-04-03 1991-04-03 Ureas and thioureas derivatives
GB919126322A GB9126322D0 (en) 1991-12-11 1991-12-11 Antiatherosclerotic disubstituted ureas and thioureas

Publications (1)

Publication Number Publication Date
MX9200665A true MX9200665A (es) 1992-08-31

Family

ID=27265519

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9200665A MX9200665A (es) 1991-02-19 1992-02-18 Derivados de ureas y tioureas disubstituidas, procedimiento para su preparacion y composiciones farmaceuticas que los contiene.

Country Status (19)

Country Link
US (1) US5264441A (es)
EP (1) EP0500348B1 (es)
JP (1) JPH04338373A (es)
KR (1) KR920016416A (es)
AT (1) ATE122670T1 (es)
AU (1) AU648143B2 (es)
CA (1) CA2061447A1 (es)
DE (1) DE69202491T2 (es)
DK (1) DK0500348T3 (es)
ES (1) ES2075610T3 (es)
FI (1) FI920656A (es)
GR (1) GR3017065T3 (es)
HU (1) HUT60259A (es)
IE (1) IE67966B1 (es)
IL (1) IL100915A (es)
MX (1) MX9200665A (es)
MY (1) MY130090A (es)
NZ (1) NZ241595A (es)
RU (1) RU2090555C1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9316020D0 (en) * 1993-08-03 1993-09-15 Erba Carlo Spa Urea and thiourea derivatives and process for their preparation
GB9504066D0 (en) * 1995-03-01 1995-04-19 Pharmacia Spa Phosphate derivatives of ureas and thioureas
AU1117497A (en) * 1995-11-13 1997-06-05 Albany Medical College Analgesic compounds and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4623662A (en) * 1985-05-23 1986-11-18 American Cyanamid Company Antiatherosclerotic ureas and thioureas
US4387105A (en) * 1982-01-26 1983-06-07 American Cyanamid Company Methods of treating atherosclerosis with dialkylureas and dialkylthioureas
US5003106A (en) * 1983-07-19 1991-03-26 American Cyanamid Company Antiatherosclerotic ureas and thioureas
IE61716B1 (en) * 1987-06-02 1994-11-30 Warner Lambert Co Antihyperlipidemic and antiatherosclerotic urea compounds
US5015644A (en) * 1987-06-02 1991-05-14 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds
JPH0193569A (ja) * 1987-07-02 1989-04-12 Warner Lambert Co アシル‐CoA:コレステロールアシルトランスフエラーゼのN‐〔(2,6‐ジ置換)フエニル〕尿素およびカルバメート阻害剤
US5116848A (en) * 1988-03-30 1992-05-26 Warner-Lambert Company N-(((2,6-disubstituted)phenyl)-n-diarylalkyl)ureas as antihyperlipidemic and antiatherosclerotic agents
US4868210A (en) * 1988-03-30 1989-09-19 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
JPH0678298B2 (ja) * 1988-03-30 1994-10-05 ワーナー‐ランバート・コンパニー N‐〔〔(2,6‐ジ置換)フエニル〕‐n′‐アリールアルキル〕尿素
GB8827152D0 (en) * 1988-11-21 1988-12-29 Wellcome Found Anti-atherosclerotic diaryl compounds
PT93158A (pt) * 1989-02-17 1990-08-31 Warner Lambert Co Processo para a preparacao de compostos de ureia trissubstituidos e de composicoes farmaceuticas que os contem
AU632809B2 (en) * 1989-05-25 1993-01-14 Takeda Chemical Industries Ltd. Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof
JPH0395153A (ja) * 1989-06-15 1991-04-19 Mitsubishi Kasei Corp ジフェニル尿素誘導体
CA2022346A1 (en) * 1989-08-04 1991-02-05 Mitsubishi Chemical Corporation 1-phenylalkyl-3-phenylurea derivatives
JPH05310678A (ja) * 1990-01-22 1993-11-22 Mitsubishi Kasei Corp 1−フェニルアルキル−3−フェニル尿素誘導体

Also Published As

Publication number Publication date
EP0500348A1 (en) 1992-08-26
AU648143B2 (en) 1994-04-14
IL100915A0 (en) 1992-11-15
KR920016416A (ko) 1992-09-24
HUT60259A (en) 1992-08-28
GR3017065T3 (en) 1995-11-30
HU9200425D0 (en) 1992-04-28
DE69202491D1 (de) 1995-06-22
IE67966B1 (en) 1996-05-15
CA2061447A1 (en) 1992-08-20
US5264441A (en) 1993-11-23
EP0500348B1 (en) 1995-05-17
JPH04338373A (ja) 1992-11-25
DE69202491T2 (de) 1995-10-12
ES2075610T3 (es) 1995-10-01
IE920507A1 (en) 1992-08-26
ATE122670T1 (de) 1995-06-15
IL100915A (en) 1996-03-31
DK0500348T3 (da) 1995-07-10
NZ241595A (en) 1994-07-26
MY130090A (en) 2007-05-31
AU1093692A (en) 1992-08-27
FI920656A0 (fi) 1992-02-14
FI920656A (fi) 1992-08-20
RU2090555C1 (ru) 1997-09-20

Similar Documents

Publication Publication Date Title
MX9201244A (es) Aminoguanidinas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
NO950009L (no) Heterocykliske forbindelser som farmasöytika
ES2173074T3 (es) Derivados de xantina, procedimiento para su preparacion y su uso farmaceutico.
ES2032750T3 (es) Profarmacos de rapamicina.
ES2102478T3 (es) Complejos de vanadio, su preparacion y composiciones farmaceuticas que los contienen.
ES2137915T3 (es) Derivados de tiazolidindiona sustituida.
FI915970A0 (fi) Laekemedel, som aer nyttiga vid vaord av cancer och som har antihistaminegenskaper.
ES2098023T3 (es) Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen.
ES2056073T3 (es) Aril-aralquil-eteres, procedimientos para su preparacion y composicion farmaceutica que los comprende.
DK268289D0 (da) Cephemforbindelser og fremgangsmaade til fremstilling deraf
MX9200665A (es) Derivados de ureas y tioureas disubstituidas, procedimiento para su preparacion y composiciones farmaceuticas que los contiene.
ATE116647T1 (de) Thiophenderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ES2084120T3 (es) Medicamentos para prevenir y tratar enfermedades del aparato circulatorio que contienen compuestos de espiro-3-heteroazolidina.
PT83975B (pt) Processo para a preparacao de derivados de 5-aminoalquil-beta-carbolinas e de composicoes farmaceuticas que os contem
DK614989D0 (da) Indolderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
FR2448544A1 (fr) Derives de thiazole et leur application en therapeutique
DE3781249T2 (de) Einige cycloalka(b)pyrazolo(3,4-d)pyridin-3-on-derivate.
RU93059589A (ru) Производные пропеновой кислоты. промежуточные соединения. композиция. способ борьбы с патогенными грибками